Jeffrey Cohen: Okay, perfect. That does it for us. Thanks for taking the questions.
Brian Baker: Thank you, Jeff.
John Krier: Thank you, Jeff.
Operator: Thank you. [Operator Instructions] The next question is from Scott Henry from ROTH Capital. Please go ahead.
Scott Henry: Thank you. Good morning. Just a couple questions. First is the 10-Q available, I didn’t see it on your website yet?
John Krier: Hi, Scott. This is John. It is not out there yet. It’ll be out by Monday with the holiday being observed tomorrow for Veterans Day. So you can expect the Q on Monday.
Scott Henry: Okay. Thank you. And good luck as well, John. Always enjoyed working with you. Shifting gears, when we think about, and I know you don’t want to give any guidance, so I’m not going to ask you about 2024, but when we think about 2025, I mean, do we think that’s the year that maybe you start to get back to more traditional organic growth for the category? And what kind of – where do you see the category as a whole growing, orthopedics and/or physical therapy? And then I guess, by then would you be hoping to take share or do you think you’d still be losing share?
Brian Baker: I think, Scott, you pointed out the two business units that we view what we have in the business with physical therapy or rehab and in our orthopedic bracing space. And so I’ll break those out into two answers, starting with the orthopedic bracing, the Bird & Cronin product line. We believe that our core competency is how we source from overseas with large items, large demand items, and how we manage that through an efficient operational process, and are able to support our customers with the way we manage their inventory requirements. And then, we believe we got a core competency with our Cut and Sew operation in our manufacturing facility here in Eagan, Minnesota to support those lower volume items. And so we continue to leverage those core competencies as we start to talk to our customers about how we can expand the relationship.
So that’s where I think the organic growth is going to come with orthopedic bracing. Going into the rehab side of the business, I think we have really good relationships with distributors and dealers that have access to the end users where our capital is coming from and from a demand perspective. And I think that the way we see some organic growth there is what I mentioned earlier, some of these very targeted new product launches. And I think as we launch these new products, we’re going to get some additional pull-through sales because we’re now going to be able to support their full product portfolio requirements. And so, not only will we get demand on these new products, but the existing products that we produce out on our New Jersey side will start to get that additional demand as they switch over from a competitor to our product line.
So that’s what I see in terms of opportunity for growth going into this fiscal year and into fiscal year 2025.
Scott Henry: And when you think about, I appreciate all the color on those segments, but when you think about how fast they are growing. I mean, do you think they’re growing 5% a year or maybe a little lower, maybe 3% or 4%? What is kind of the category growth?
John Krier: Yes, I think it’s too soon if you’re asking specific growth in this year into the next year. Talking in terms of where I see the opportunity, I can’t relate that back into percentage of growth for you right now, Scott.
